Intravenous Administration of a Single-Dose Free-Circulating DNA of Colitic Origin Improves Severe Murine DSS-Colitis

Pathology and Oncology Research

Volumn 20, Issue 4, 2014, Pages 867-877

  Sipos, Ferenc ^a   Műzes, Györgyi ^a   Fűri, István ^a   Spisák, Sándor ^b,c   Wichmann, Barnabás ^a   Germann, Tiana M ^a   Constantinovits, Miklós ^a   Krenács, Tibor ^a   Tulassay, Zsolt ^a,c   Molnár, Béla ^a,c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

DSS colitis; Free circulating DNA; Proinflammatory cytokines; Tissue regeneration; Toll like receptor 9

Indexed keywords

DEXTRAN SULFATE; DNA; MESSENGER RNA; TLR9 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 9;

ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; COLITIS; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADMINISTRATION, INTRAVENOUS; ANIMALS; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DNA; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 9;

EID: 84936144928     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-014-9766-x     Document Type: Article

References (58)

1. van Dieren JM, Kuipers EJ, Samsom JN et al (2006) Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD. Inflamm Bowel Dis 12:311–327
2. Tan EM, Schur PH, Carr RI et al (1966) Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 11:1732–1740
3. Leon SA, Shapiro B, Sklaroff DM et al (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 3:646–650
4. Kohler C, Barekati Z, Radpour R et al (2011) Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res 8:2623–2628
5. Steinman CR (1975) Free DNA in serum and plasma from normal adults. J Clin Invest 56:512–515
6. Rauh P, Rickes S, Fleischhacker M (2003) Microsatellite alterations in free-circulating serum DNA in patients with ulcerative colitis. Dig Dis 21:363–366
7. Swarup V, Rajeswari MR (2007) Circulating (cell-free) nucleic acids—a promising, non-invasive tool for early detection of several human diseases. FEBS Lett 581:795–799
8. Gosu V, Basith S, Kwon OP et al (2012) Therapeutic applications of nucleic acids and their analogues in Toll-like receptor signaling. Molecules 17:13503–13529
9. Nierkens S, den Brok MH, Garcia Z et al (2011) Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells. Cancer Res 71:6428–6437
10. Liang X, Moseman EA, Farrar MA et al (2010) Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells. Blood 115:5041–5052
11. Sipos F, Műzes G (2011) Isolated lymphoid follicles in colon: switch points between inflammation and colorectal cancer? World J Gastroenterol 17:1666–1673
12. Dieleman LA, Ridwan BU, Tennyson GS et al (1994) Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107:1643–1652
13. Egger B, Bajaj-Elliott M, MacDonald TT et al (2000) Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62:240–248
14. Rachmilewitz D, Karmeli F, Takabayashi K et al (2002) Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 122:1428–1441
15. Ciorba MA, Bettonville EE, McDonald KG et al (2010) Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis. J Immunol 184:3907–3916
16. Dou S, Smith M, Wang Y et al (2013) Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy. Cancer Biother Radiopharm
17. Musch E, Lutfi T, von Stein P et al (2013) Topical treatment with the toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity. Inflamm Bowel Dis 19:283–292
18. Murthy SN, Cooper HS, Shim H et al (1993) Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 38:1722–1734
19. te Velde AA, Verstege MI, Hommes DW (2006) Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis 12:995–999
20. Duijvestein M, Wildenberg ME, Welling MM et al (2011) Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells 29:1549–1558
21. Lee JS, Oka K, Obara M et al (2009) Improved isolation methods for mucosal leukocytes from small and large intestines in rats. Biosci Biotechnol Biochem 73:1732–1740
22. Hart AL, Al-Hassi HO, Rigby RJ et al (2005) Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129:50–65
23. Howe R, Dillon S, Rogers L et al (2009) Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria. Clin Immunol 131:317–332
24. Stenson WF (2008) Toll-like receptors and intestinal epithelial repair. Curr Opin Gastroenterol 24:103–107
25. Ishii KJ, Akira S (2005) Innate immune recognition of nucleic acids: beyond toll-like receptors. Int J Cancer 117:517–523
26. Ishii KJ, Gursel I, Gursel M et al (2004) Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides. Curr Opin Mol Ther 6:166–174
27. Krieg AM, Wu T, Weeratna R et al (1998) Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A 95:12631–12636
28. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427–434
29. Rachmilewitz D, Katakura K, Karmeli F et al (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126:520–528
30. Gormally E, Caboux E, Vineis P et al (2007) Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 635:105–117
31. Stroun M, Maurice P, Vasioukhin V et al (2000) The origin and mechanism of circulating DNA. Ann N Y Acad Sci 906:161–168
32. Model F, Osborn N, Ahlquist D et al (2007) Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease. Mol Cancer Res 5:153–163
33. Li L, Choi JY, Lee KM et al (2012) DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiology. J Epidemiol 22:384–394
34. Tóth K, Sipos F, Kalmár A et al (2012) Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PLoS One 7:e46000
35. Philipp AB, Stieber P, Nagel D et al (2012) Prognostic role of methylated free circulating DNA in colorectal cancer. Int J Cancer 131:2308–2319
36. Gorges TM, Schiller J, Schmitz A et al (2012) Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA. Biomarkers 17:498–506
37. Műzes G, Molnár B, Tulassay Z et al (2012) Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol 18:5848–5861
38. Dieleman LA, Palmen MJ, Akol H et al (1998) Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114:385–391
39. Rykova EY, Morozkin ES, Ponomaryova AA et al (2012) Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content. Expert Opin Biol Ther 12(Suppl 1):S141–S153
40. Iriyama C, Tomita A, Hoshino H et al (2012) Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome. Biochem Biophys Res Commun 419:662–669
41. Constantinovits M, Sipos F, Molnár B et al (2012) Organizer and regulatory role of colonic isolated lymphoid follicles in inflammation. Acta Physiol Hung 99:344–352
42. Saleh M, Trinchieri G (2011) Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol 11:9–20
43. Muroi M, Tanamoto K (2008) TRAF6 distinctively mediates MyD88- and IRAK-1-induced activation of NF-kappaB. J Leukoc Biol 83:702–707
44. Kawagoe T, Sato S, Matsushita K et al (2008) Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat Immunol 9:684–691
45. Kawai T, Akira S (2007) Antiviral signaling through pattern recognition receptors. J Biochem 141:137–145
46. Zhu J, Mohan C (2010) Toll-like receptor signaling pathways—therapeutic opportunities. Mediat Inflamm 2010:781235
47. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376
48. Berglund M, Thomas JA, Fredin MF et al (2009) Gender dependent importance of IRAK-1 in dextran sulfate sodium induced colitis. Cell Immunol 259:27–32
49. Honda K, Yanai H, Mizutani T et al (2004) Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci U S A 101:15416–15421
50. Honda K, Yanai H, Negishi H et al (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772–777
51. Uematsu S, Sato S, Yamamoto M et al (2005) Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-(alpha) induction. J Exp Med 201:915–923
52. Nenci A, Becker C, Wullaert A et al (2007) Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446:557–561
53. Moss BL, Elhammali A, Fowlkes T et al (2012) Interrogation of inhibitor of nuclear factor κB α/nuclear factor κB (IκBα/NF-κB) negative feedback loop dynamics: from single cells to live animals in vivo. J Biol Chem 287:31359–31370
54. Lee J, Mo JH, Katakura K et al (2006) Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8:1327–1336
55. Katakura K, Lee J, Rachmilewitz D et al (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115:695–702
56. Sivakumar PV, Westrich GM, Kanaly S et al (2002) Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50:812–820
57. Takagi H, Kanai T, Okazawa A et al (2003) Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand J Gastroenterol 38:837–844
58. Tóth K, Galamb O, Spisák S et al (2009) Free circulating DNA based colorectal cancer screening from peripheral blood: the possibility of the methylated septin 9 gene marker. Orv Hetil 150:969–977